Imaging Doxorubicin Free Radical in Mice with Overhauser Enhanced MRI and its Tumor Suppression Effect in Mice
- Autores: Kato N.1, Sato S.2, Yamada K.2, Ichikawa K.1,3,4
-
Afiliações:
- Innovation Center for Medical Redox Navigation, Kyushu University
- Graduate School of Pharmaceutical Sciences, Kyushu University
- Incubation Center for Advanced Medical Science, Kyushu University
- Department of Biophysical Chemistry, Faculty of Pharmaceutical Sciences, Nagasaki International University
- Edição: Volume 49, Nº 8 (2018)
- Páginas: 869-879
- Seção: Original Paper
- URL: https://journals.rcsi.science/0937-9347/article/view/248068
- DOI: https://doi.org/10.1007/s00723-018-1004-3
- ID: 248068
Citar
Resumo
In the treatment with anticancer drugs, it is important to deliver an anticancer agent to target site of the tumor at an appropriate concentration. However, it is difficult to directly measure the distribution amount of the agent and effect of anticancer drug is evaluated using its tumor suppression effect. In this study, we report an approach to visualizing an anticancer agent distribution in tumor-bearing mouse model using Overhauser enhanced magnetic resonance imaging (OMRI). The agent, doxorubicin, is one of anthracycline anticancer drugs and can form a free radical at its quinone sites and could be visualized using OMRI. After direct injection into a tumor, doxorubicin free radical was successfully imaged in tumor-bearing mouse, demonstrating practical usefulness of OMRI in the study of pharmacodynamics of free radical compounds. Imaging of antitumor agent would be potentially useful as a guidance tool for image-guided-therapy of cancer local chemotherapy.
Sobre autores
Nao Kato
Innovation Center for Medical Redox Navigation, Kyushu University
Email: ichikawak@niu.ac.jp
Japão, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582
Suguru Sato
Graduate School of Pharmaceutical Sciences, Kyushu University
Email: ichikawak@niu.ac.jp
Japão, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582
Ken-ichi Yamada
Graduate School of Pharmaceutical Sciences, Kyushu University
Email: ichikawak@niu.ac.jp
Japão, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582
Kazuhiro Ichikawa
Innovation Center for Medical Redox Navigation, Kyushu University; Incubation Center for Advanced Medical Science, Kyushu University; Department of Biophysical Chemistry, Faculty of Pharmaceutical Sciences, Nagasaki International University
Autor responsável pela correspondência
Email: ichikawak@niu.ac.jp
ORCID ID: 0000-0002-5022-6812
Japão, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582; 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582; Huis Ten Bosch, Sasebo, Nagasaki, 859-3298
Arquivos suplementares
